BioPharm International-12-01-2015

December 01, 2015

Subjective visual evaluation of freeze-dried products can be quantified through mechanical methods of characterizing the properties these materials.

December 01, 2015

BioPharm International sat down with Kevin Isett, PhD, co-founder and CEO of Avitide, to find out why he thinks the company’s tailored approach to purification resins will change the face of biopharmaceutical separation.

December 01, 2015

Use of a subspace model is a viable method to characterize process space variables and optimize process performance.

December 01, 2015

The authors evaluate the SoloVPE technique as a replacement for nitrogen-based protein determination.

December 01, 2015

FDA confirmed quality focus while Congress moved to bolster biomedical innovation.

December 01, 2015

CMO industry consolidation may be frustrated by a dearth of attractive assets.

December 01, 2015

Expectations are high for rapid testing methods, but demonstration of comparability proves challenging.

December 01, 2015

Advances in glycan analysis are enhancing biologics development and quality control processes.

December 01, 2015

Biopharma employees in different market segments note subtle differences in job satisfaction.

December 01, 2015

Finalizing GMP requirements and quality standards for the development, manufacture, and clinical testing of ATMPs in the EU is proving to be a complex task.

December 01, 2015

Limited career and salary growth complicate a somewhat positive employment picture.

December 01, 2015

Click the title above to open the BioPharm International December 2015 issue in an interactive PDF format.